{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["27(Suppl 2)"],"submitter":["Margaret T"],"journal":["Annals of oncology : official journal of the European Society for Medical Oncology"],"pagination":["ii84-ii84"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC4984075"],"repository":["biostudies-literature"],"pubmed_title":["P-288Global Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Compare Efficacy and Safety of PEGylated Recombinant Human Hyaluronidase (PEGPH20) Plus nab-Paclitaxel and Gemcitabine vs. Placebo Plus nab-Paclitaxel and Gemcitabine"],"pmcid":["PMC4984075"],"pubmed_authors":["Andrew H","Dimitrios C","Wilson W","Eric V","Tara S","Michel D","Andrea B","Margaret T","Lei Z","William H","Pippa C","Volker H","Sunil H","Michele R"],"additional_accession":[]},"is_claimable":false,"name":"P-288Global Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Compare Efficacy and Safety of PEGylated Recombinant Human Hyaluronidase (PEGPH20) Plus nab-Paclitaxel and Gemcitabine vs. Placebo Plus nab-Paclitaxel and Gemcitabine","description":null,"dates":{"release":"2016-01-01T00:00:00Z","publication":"2016 Jun","modification":"2025-04-26T20:35:17.076Z","creation":"2025-04-06T16:26:35.585Z"},"accession":"S-EPMC4984075","cross_references":{}}